These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 194368)

  • 1. T-cell-dependent reactivity against tumor-associated antigens on allogeneic target cells.
    Holden HT; Landolfo S; Herberman RB
    Transplant Proc; 1977 Mar; 9(1):1149-52. PubMed ID: 194368
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F; Jongeneel CV
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
    Landolfo S; Herberman RB; Holden HT
    J Immunol; 1977 Apr; 118(4):1244-8. PubMed ID: 191532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays.
    Fossati G; Holden HT; Herberman RB
    Cancer Res; 1975 Sep; 35(9):2600-8. PubMed ID: 167966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central problems in tumor immunology, 1976.
    Weiss DW
    Isr J Med Sci; 1976; 12(4-5):281-7. PubMed ID: 1084878
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells.
    Brunner KT; MacDonald HR; Cerottini JC
    J Immunol; 1980 Apr; 124(4):1627-34. PubMed ID: 6154076
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization and specificity of murine anti-tumor cytotoxic effector cells within an ascitic tumor.
    Biddison WE; Palmer JC; Alexander MA; Cowan EP; Manson LA
    J Immunol; 1977 Jun; 118(6):2243-53. PubMed ID: 68083
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular immunity to tumor-associated antigens of transplantable mammary tumors of C3H/HeN mice.
    Tagliabue A; Herberman RB; Arthur LO; McCoy JL
    Cancer Res; 1979 Jan; 39(1):35-41. PubMed ID: 83909
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kinetics of production of macrophage migration inhibitory factors in mixed culture of lymphocytes and tumor cells].
    Kharkevich DD; Suslov AP
    Biull Eksp Biol Med; 1982 Feb; 93(2):53-5. PubMed ID: 6461371
    [No Abstract]   [Full Text] [Related]  

  • 11. [Differences in the expression of a differentiation antigen of activated cells (ACA-1) on T killer cells and on MIF-producing cells].
    Nesterenko VG; Egorova SG; Suslov AP
    Biull Eksp Biol Med; 1983 Jan; 95(1):68-9. PubMed ID: 6338956
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.
    Landolfo S; Herberman RB; Holden HT
    J Natl Cancer Inst; 1977 Dec; 59(6):1675-83. PubMed ID: 200758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between cytotoxic lymphocytes and cells that synthesize the macrophage migration inhibitory factor in the H-2 system].
    Suslov AP; Egorova SG; Brondz BD
    Biull Eksp Biol Med; 1975 Oct; 80(10):86-90. PubMed ID: 776251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunity to H-2 antigens. Characteristics of the effector cells as detected in the microcytotoxicity assay.
    Trostmann H; Pfizenmaier K; Wagner H; Röllinghoff M
    Transplantation; 1976 Jun; 21(6):446-53. PubMed ID: 1084606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated allograft responses in vitro. VI. Studies on macrophage-mediated cytotoxicity.
    Pfizenmaier K; Trostmann H; Röllinghoff M; Wagner H
    Immunology; 1975 Dec; 29(6):967-76. PubMed ID: 1081494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigens.
    Fujiwara H; Hamaoka T; Teshima K; Aoki H; Kitagawa M
    Immunology; 1976 Aug; 31(2):239-48. PubMed ID: 1085283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
    Mortensen RF
    J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problems of specific cellular immunity against influenza].
    Shvartsman IaS; Ispolatova AV; Tsybul'skaia NV
    Usp Sovrem Biol; 1979; 88(1):77-92. PubMed ID: 388905
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of the immune response in tumor-bearing mice. I. Response to virus-producing tumor cells and non-virus-producing tumor cells.
    Bluestone JA; Lopez C
    J Natl Cancer Inst; 1979 Nov; 63(5):1215-20. PubMed ID: 228105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.